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SUMMARY
Infusions of catecholamines are frequently administered to patients receiving propofol or isoflurane anaesthesia.
Interactions between these drugs may affect regional circulations, such as the brain.
The aim of this animal (sheep) study was to determine the effects of ramped infusions of adrenaline, noradrenaline
(10, 20, 40 µg/min) and dopamine (10, 20, 40 µg/kg/min) on cerebral blood flow (CBF), intracranial pressure (ICP),
cerebrovascular resistance (CVR) and cerebral metabolic rate for oxygen (CMRO2). These measurements were made
under awake physiological conditions, and during continuous propofol (15 mg/min) or 2% isoflurane anaesthesia.
All three catecholamines significantly and equivalently increased mean arterial pressure from baseline in a dose-
dependent manner in the three cohorts (P<0.001). In the awake cohort (n=8), dopamine (P<0.01) significantly
increased CBF from baseline whilst adrenaline and noradrenaline did not (P>0.05). Under propofol (n=6) and
isoflurane (n=6), all three catecholamines significantly increased CBF (P<0.001). Dopamine caused the greatest
increase in CBF, and was associated with significant increases in ICP (awake: P<0.001; propofol P<0.05; isoflurane
P<0.001) and CVR (isoflurane P<0.05). No significant changes in CMRO2 were demonstrated.
Under propofol and isoflurane anaesthesia, the cerebrovascular effects of catecholamines were significantly
different from the awake, physiological state, with dopamine demonstrating the most pronounced effects, particularly
under propofol. Dopamine-induced hyperaemia was associated with other cerebrovascular changes. In the presence
of an equivalent effect on mean arterial pressure, the exaggerated cerebrovascular effects under anaesthesia appear 
to be centrally mediated, possibly induced by propofol- or isoflurane-dependent changes in blood-brain barrier
permeability, thereby causing a direct influence on the cerebral vasculature.
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Defence of systemic blood pressure forms the
cornerstone of intensive care medicine and anaes-
thesia. This is usually achieved by using infusions of
catecholamines such as adrenaline, noradrenaline or
dopamine. These drugs are frequently administered
to sedated or anaesthetized patients receiving
intravenous agents such as propofol, or volatile
anaesthetics such as isoflurane.
The direct effect of catecholamines on the cerebral
circulation under physiological and pathophysio-
logical conditions remains contentious, due to
variability of experimental models and methods of
measurement of cerebrovascular mechanics. Within
physiological autoregulatory limits, catecholamines
do not cross the intact blood-brain barrier, thereby
limiting their direct cerebrovascular effects. How-
ever, this effect may be altered by changes in blood-
brain barrier permeability or by systemic physio-
logical perturbations (e.g. systemic hypertension)
1.
Anaesthetic agents such as propofol or isoflurane
may affect the physiological function of the blood-
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Accepted for publication on July 28, 2002.brain barrier due to alterations of blood-brain barrier
permeability
2,3. Propofol and isoflurane may also
affect carbon dioxide (CO2) reactivity or pressure
(myogenic) autoregulation
4. Consequently, the inter-
action of exogenous catecholamine infusions under
propofol or isoflurane anaesthesia may result in
direct effects on the cerebral vasculature.
The aim of this study was to determine the effects
of adrenaline, noradrenaline and dopamine on
cerebral blood flow, intracranial pressure, cerebro-
vascular resistance and cerebral metabolic rate for
oxygen under continuous propofol and isoflurane
anaesthesia. These effects were compared with each
other and with the physiological (non-anaesthetized)
state.
METHOD
Studies were performed in three cohorts of instru-
mented adult Merino ewes: awake or anaesthetized
with steady state propofol or isoflurane.
The Animal Ethics Committee of the University of
Adelaide approved the study. Animals were handled
in accordance with the Australian Code of Practice
for the Care and Use of Animals for Scientific
Purposes.
Animal preparation
Female Merino sheep of similar ages and body
mass were used. The animals were instrumented
under thiopentone and halothane anaesthesia as
described previously
5. In brief, a 2 cm frontal
craniotomy was performed anterior to the trifurca-
tion of the frontal and parietal sutures. A bony plate
was removed using a trephine and the extradural
portion of the sagittal sinus exposed. 
Using a Seldinger wire, a 4F polyethylene catheter
(Cook Incorporated, Bloomington, U.S.A.) was
inserted into the sagittal sinus for intermittent
sampling of cerebral venous blood for oxygen content
determination. An ultrasonic, range-gated Doppler
transducer (Tritonics Medical instruments, Iowa) was
placed on the dorsal sagittal sinus. A strain-gauge
tipped intracranial pressure monitor (Microsensor
ICP Transducer, Codman, Randolph MA, U.S.A.)
was placed into the subdural space through the same
craniotomy. The Doppler transducer, intracranial
pressure monitor and sagittal sinus catheter were
then secured under the replaced bone plug which was
fixed with a plate and bone screws. 
The animal was then turned supine and the
femoral triangle exposed. A 7F catheter (Multi-
purpose A1 catheter, Cordis Corporation, Miami,
U.S.A.) was inserted into the femoral artery for
measurement of mean arterial pressure, intermittent
sampling of arterial blood gases and into the femoral
vein for drug and fluid delivery. Through the femoral
venotomy, a thermodilution pulmonary artery
catheter (Model TD1755H, Biosensors International,
Singapore) was inserted and positioned into the
pulmonary artery under waveform imaging.
A single dose of penicillin/streptomycin was
administered perioperatively for antibiotic prophy-
laxis. Catheter patency was maintained by intra-
luminal heparin (10 IU/ml) locks.
Sheep were recovered and returned to housing
crates where they were allowed free access to food
and water.
A period of five days elapsed between insertion
and measurements to allow a fibrous scar to develop
around the flowmeter and the sagittal sinus. This
ensured minimal movement between the two and a
constant angle between the ultrasonic beam and the
direction of blood flow.
Sample size determination
The sample size required to determine baseline
stability within and between cohorts and repro-
ducibility of each intervention was determined from
previous studies using our experimental prepara-
tion
6-8. Due to the homogeneity and stability of 
the preparation, six studies for each intervention 
(i.e. catecholamine infusion) were considered
appropriate. Stability and reproducibility were
evaluated by determining normality of distribution
and 95% confidence interval analysis. This is 
an appropriate approach for an interventional
physiological study.
Awake studies
On the day of study, each sheep was moved to a
specific study laboratory. The animal was supported
by a sling and extraneous noise was minimized to
reduce changes in cerebral blood flow induced by
changes its state of arousal. Monitoring lines were
connected and the animal was allowed to settle so
that a period of baseline stability was achieved before
commencement of catecholamine infusions.
Anaesthetized studies
Prior to anaesthesia, the output of the Doppler
probes was recorded with the animal in an awake,
calm state. Anaesthesia was then induced (see below)
and the animal was turned supine and endotracheally
intubated. Ventilation was controlled using a volume
control ventilator (7000 Ventilator, Ohmeda,
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CO2 was measured with an infrared analyser
(Capnomac, Datex Instrumentarium Corp, Helsinki,
Finland) and mechanical ventilation was adjusted to
maintain end-tidal CO2 at 40 mmHg. 
The animal was then turned prone and placed in
the sphinx position for studies. 
Animals anaesthetized with propofol were induced
with 200 mg propofol. Propofol was delivered intra-
venously via a syringe driver (Model 33, Harvard
Apparatus, MA, U.S.A.) at a constant rate of 
15 mg/min. This rate was selected based on pre-
viously published studies from our laboratory
analysing the cerebral pharmacokinetics of propofol
in sheep
7,9,10.
Animals anaesthetized with isoflurane were
induced with thiopentone 1000 mg and isoflurane
delivered by a vaporizer (Isotec 3, Ohmeda BOC
Group, U.K.) to maintain an expired concentration 
of 2%, measured by a volatile agent detector
(Capnomac, Datex Instrumentarium Corp, Helsinki,
Finland). Two per cent isoflurane concentrations
were selected in accordance with previous studies
demonstrating adequacy of anaesthesia and stability
of cerebrovascular volumes
11.
After 1.5 hours to allow the induction agent to
clear and for anaesthetic conditions to reach steady
state, baseline measurements of cerebral blood flow,
mean arterial pressure, intracranial pressure and
blood gases were recorded. 
Interventions
Using a random number generator (StatMate®,
GraphPad Software, San Diego, U.S.A.), each animal
received a randomly allocated ramped intravenous
infusion of noradrenaline, adrenaline or dopamine
through the femoral venous catheter. Each animal
acted as its own control. Infusions of noradrenaline
and adrenaline (10, 20, 40 µg/min) and dopamine (10,
20, 40 µg/kg/min) were administered for five-minute
intervals, followed by a washout period of 20 minutes.
One hour elapsed between completion of each study
to ensure clearance of each catecholamine and
restoration of baseline values.
Hydration was maintained throughout all studies
by intravenous infusion of one litre per hour of
normal saline. Temperature was monitored via the
pulmonary artery catheter and maintained at baseline
levels via humidification of inspired gases using a
heat and moisture exchanger.
Following the studies, sheep were recovered and
transferred to holding crates where they were allowed
free access to food and water.
Measurements
Changes in cerebral blood flow were inferred from
changes in the outputs from the Doppler probe. Once
a period of baseline stability was established, Doppler
frequencies were expressed as a percentage of the
reading obtained in the baseline period. This was
sampled at 1Hz using an analog to digital card
(Metrabyte DAS 16-G2) and a personal computer
(Microbits 486-based IBM compatible) and recorded
digitally on computer disk.
Mean arterial and intracranial pressures were
recorded using a standard transducer and amplifier
(78342A, Hewlett Packard Company, U.S.A.) and
recorded through the same computerized data acqui-
sition system. Both were recorded as percentage
changes from baseline values and averaged over the
last two minutes of each rate of catecholamine infu-
sion. This was done in accordance with the expected
half-lives of the catecholamine.
An index of cerebrovascular resistance was calcu-
lated using the standard formula: cerebral perfusion
pressure (mean arterial pressure—intracranial
pressure) divided by cerebral blood flow.
Blood was sampled for blood gas analysis from the
femoral arterial and sagittal sinus catheters and
measured using a standard blood gas analyser (ABL
625, Radiometer Medical, Copenhagen, Denmark).
Samples were taken at five-minute intervals through-
out each study. Arterial and sagittal sinus oxygen
contents were derived from oxygen saturation and
haemoglobin. Carbon dioxide tensions and pH were
also measured. 
Cerebral metabolic rate for oxygen (CMRO2) was
calculated using the standard formula: cerebral blood
flow x arterio-venous oxygen content difference.
Data analysis
Gaussian distribution of datapoints before para-
metric analyses was determined using the Kol-
mogorov-Smirnov test. The effect of anaesthesia on
cerebral blood flow (pre-anaesthesia vs 1.5 hours post
anaesthesia induction) was examined using a paired 
t-test.
Data for changes over time for each catecholamine
under each condition was averaged into five-minute
intervals using data compression and averaging soft-
ware programs. These values corresponded to the
changes in rates of infusion and into the post-infusion
washout period. 
Comparison between time intervals and between
groups was determined using two-way analysis of
variance and Bonferroni corrections for multiple time
points
12. Significance was determined by 95% confi-
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of <0.05 was considered to be statistically significant.
RESULTS
In the awake cohort, studies with each cate-
cholamine were conducted in eight animals, and in six
animals for each catecholamine in the propofol and
isoflurane cohorts. 
Propofol anaesthesia was characterized by a sub-
stantial, statistically significant decrease in cerebral
blood flow (55% of baseline, P=0.001) and a signifi-
cant increase in mean arterial pressure (132.4% 
baseline,  P=0.04). Isoflurane anaesthesia did not
significantly change cerebral blood flow (88.45% of
baseline, P=0.39) or mean arterial pressure (97.6%
of baseline, P=0.76).
All three catecholamines significantly increased
mean arterial pressure from baseline in a dose-
dependent manner in the three cohorts (P<0.001).
There was no statistically significant difference
between each catecholamine in any of the cohorts
(P>0.05) (Figures 1a, 1b, 1c).
In the awake cohort, cerebral blood flow was sig-
nificantly increased by dopamine (P<0.01), but not
by adrenaline or noradrenaline (P>0.05) (Figure 2a).
In the propofol cohort, adrenaline, noradrenaline
and dopamine significantly increased cerebral blood
flow from baseline (P<0.001). Dopamine increased
cerebral blood flow significantly greater than nora-
drenaline at the highest infusion concentrations
(P<0.01) (Figure 2b).
In the isoflurane cohort, adrenaline, noradrenaline
and dopamine significantly increased cerebral blood
flow from baseline (P<0.001). There was no statisti-
cally significant difference between each cate-
cholamine under isoflurane (P>0.05) (Figure 2c).
Dopamine increased cerebral blood flow sig-
nificantly greater under propofol than isoflurane
anaesthesia (P<0.001).
The effects on intracranial pressure are shown in
Figures 3a, 3b, 3c. In all cohorts, dopamine signifi-
cantly increased intracranial pressure from baseline
in a dose-dependent manner (awake: P<0.001;
propofol  P<0.05; isoflurane P<0.001), whilst
adrenaline and noradrenaline did not (P>0.05). 
Dopamine increased intracranial pressure signifi-
cantly greater than adrenaline and noradrenaline in
the awake cohort (P<0.001); and noradrenaline in
the propofol and isoflurane (P<0.05) cohorts.
No statistically significant changes in cerebro-
vascular resistance from baseline were demonstrated
during the infusions of adrenaline and noradrenaline
in the awake and propofol cohort (P>0.05).
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FIGURE 1: Effect of adrenaline, noradrenaline and dopamine infu-
sions on mean arterial pressure (expressed as % change from
baseline) under awake (non-anaesthetized) conditions (Figure
1a); during propofol anaesthesia (15 mg/min) (Figure 1b) and dur-
ing 2% isoflurane anaesthesia (Figure 1c). Dose refers to five-
minute intervals in µg/min for adrenaline and noradrenaline,
µg/kg/min for dopamine during infusion followed by a 20-minute
washout period. Data are expressed as mean±SEM. Asterisk (*)
refers to P<0.001 for all three catecholamines.729 CATECHOLAMINES IN PROPOFOL AND ISOFLURANE ANAESTHESIA
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FIGURE 2: Effect of adrenaline, noradrenaline and dopamine infu-
sions on cerebral blood flow (expressed as % change from base-
line) under awake (non-anaesthetized) conditions (Figure 2a);
during propofol anaesthesia (15 mg/min) (Figure 2b) and during
2% isoflurane anaesthesia (Figure 2c). Dose refers to five-minute
intervals in µg/min for adrenaline and noradrenaline, µg/kg/min
for dopamine during infusion followed by a 20-minute washout
period. Data are expressed as mean±SEM. Asterisk (*) refers to
P<0.001; hash (#) refers to P<0.01, dot (•) refers to P<0.05 for
each catecholamine for significant changes from baseline.
FIGURE 3: Effect of adrenaline, noradrenaline and dopamine infu-
sions on intracranial pressure (expressed as % change from base-
line) under awake (non-anaesthetized) conditions (Figure 3a);
during propofol anaesthesia (15 mg/min) (Figure 3b) and during
2% isoflurane anaesthesia (Figure 3c). Dose refers to five-minute
intervals in (g/min for adrenaline and noradrenaline, µg/kg/min
for dopamine during infusion followed by a 20-minute washout
period. Data are expressed as mean±SEM. Asterisk (*) refers to
P<0.001; hash (#) refers to P<0.01, dot (•) refers to P<0.05 for
each catecholamine for significant changes from baseline.Dopamine significantly increased cerebrovascular
resistance from baseline under isoflurane (P<0.001),
but not in the awake and propofol cohorts (Figures
4a, 4b, 4c).
Prompt reductions in cerebrovascular resistance
were demonstrated in all cohorts following cessation
of catecholamine infusions. These reductions were
only statistically significant following cessation of
adrenaline in the awake (P<0.05) and isoflurane
(P<0.001) cohorts, and dopamine in the propofol
(P<0.05) and isoflurane (P<0.001) cohorts. 
Adrenaline, noradrenaline and dopamine did not
significantly change CMRO2 from baseline during
the infusion and post infusion period in any of the
cohorts (P>0.05) (Figures 5a, 5b, 5c).
CMRO2 during catecholamine infusions was lower
under anaesthetized conditions compared to the
awake cohort. 
DISCUSSION
This study directly compared the effects of 
three commonly used exogenous catecholamines on
cerebrovascular mechanics and metabolism during
propofol and isoflurane anaesthesia with the physio-
logical (non-anaesthetized) state. Propofol and iso-
flurane were chosen because of their predominance
in neuroanaesthesia. Propofol is increasingly being
used as a sedative agent in critically ill patients.
There are few studies quantifying and comparing
the effects of catecholamines on cerebrovascular
mechanics. King et al compared the effects of
adrenaline (6 to 22 µg/min) and noradrenaline (19-
73 µg/min) on cerebral blood flow, measured 
using the nitrous oxide method, in awake human
volunteers
13. Induced hypertension with adrenaline
was associated with increased cerebral blood flow
that was attributed to increased cerebral metabolism.
Noradrenaline was associated with decreased cere-
bral blood flow that was attributed to increased
cerebrovascular resistance in the absence of
demonstrable changes in metabolism.
To assess and compare the effects of individual
catecholamine(s) on cerebrovascular function under
various conditions, it is important to use a stan-
dardized dose regimen and validated measurements
of cerebral blood flow, intracranial and mean arterial
pressures in a homogeneous population.
The doses of catecholamines used were selected 
to represent a clinically relevant range. Adrenaline
and noradrenaline were expressed as µg/minute,
whilst dopamine was referenced to body weight
(µg/kg/min) for familiarity reasons. These concentra-
tions may be regarded as functionally equivalent.
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FIGURE 4: Effect of adrenaline, noradrenaline and dopamine infu-
sions on cerebrovascular resistance (expressed as resistance units)
under awake (non-anaesthetized) conditions (Figure 4a); during
propofol anaesthesia (15 mg/min) (Figure 4b) and during 2%
isoflurane anaesthesia (Figure 4c). Dose refers to five-minute
intervals in µg/min for adrenaline and noradrenaline, (g/kg/min
for dopamine during infusion followed by a 20-minute washout
period. Data are expressed as mean±SEM. Asterisk (*) refers to
P<0.001 for each dopamine for significant changes from baseline.Adrenaline and noradrenaline have hydroxyl groups
on the β carbon atom of the amine chain, which is
associated with a hundred-fold greater potency than
dopamine. Dopamine is hydroxylated to form nora-
drenaline, which is subsequently methylated to form
adrenaline
14. All catecholamines have very short
biological half-lives (1 to 2 minutes) and a steady
state plasma concentration is achieved within 5 to 
10 minutes.
Our laboratory has extensive experience in the
measurement of cerebral blood flow using the range-
gated Doppler ultrasound probe venous outflow
method. Validation studies have been performed that
compared this method of cerebral blood flow against
angiographic, retrograde dye and timed venous out-
flow studies
5. This Doppler method of cerebral blood
flow measurement represents 75% total cerebral
blood flow. It has also been shown to be in agreement
with measurements made using the Kety-Schmidt
nitrous oxide method in sheep
15. Importantly, due to
the anatomical structure of the sagittal sinus in sheep,
this vessel is not subject to large variations in vessel
diameter that may invalidate velocity-based measure-
ments. Validation studies demonstrated that vessel
diameters and laminar cerebral blood flow remained
constant across a fourfold change in flow.
Consequently, flow-velocity relationships remained
constant over the range of flows studied, thereby
maintaining the correlation between flow and sinus
blood velocities.
The data from the awake cohort shows that
dopamine significantly increased cerebral blood flow
and intracranial pressure in a dose-dependent
manner without demonstrable changes in calculated
cerebrovascular resistance or cerebral oxygen extrac-
tion. The effects of dopamine on cerebral blood flow
and intracranial pressure were significantly greater
than adrenaline, which increased cerebral blood flow
albeit to a lesser extent and noradrenaline, which did
not. Of the three catecholamines, noradrenaline had
the least effect on cerebrovascular mechanics, despite
inducing an equivalent systemic effect to dopamine
and noradrenaline, suggesting little or no direct effect
on the cerebral circulation. The variance between our
results and King’s study may be explained by the dif-
ference in doses used—a standardized infusion over a
dose range compared to disparate doses in different
individuals. Cerebrovascular resistance is a derived
index that is prone to cumulative measurement
errors. Caution should be used when attributing
dynamic changes in complex systems to a single
derived index.
Under propofol and isoflurane anaesthesia, the
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FIGURE 5: Effect of adrenaline, noradrenaline and dopamine infu-
sions on cerebral metabolic rate for oxygen (CMRO2) under
awake (non-anaesthetized) conditions (Figure 5a); during propo-
fol anaesthesia (15 mg/min) (Figure 5b) and during 2% isoflurane
anaesthesia (Figure 5c). Dose refers to five-minute intervals in
µg/min for adrenaline and noradrenaline, µg/kg/min for dopamine
during infusion followed by a 20-minute washout period. Data are
expressed as mean±SEM. No significant changes from baseline
were demonstrated.cerebrovascular effects of catecholamines were sig-
nificantly different from the awake, physiological
state. Cerebral blood flow was significantly increased
by all three catecholamines under propofol and
isoflurane anaesthesia compared to the awake state,
with dopamine demonstrating the most pronounced
effects, particularly under propofol. Dopamine-
induced hyperaemia was associated with other
cerebrovascular changes. Dopamine consistently
increased both intracranial pressure and cerebro-
vascular resistance, whilst this was not a feature of
noradrenaline and adrenaline, suggesting a greater
degree of hyperaemia induced by dopamine. In the
presence of an equivalent effect on mean arterial
pressure, these cerebrovascular effects appear to be
centrally mediated, possibly induced by propofol or
isoflurane-mediated changes in blood-brain barrier
permeability, thereby causing a direct influence on
the cerebral vasculature.
Cerebral metabolic rate for oxygen, used as a
surrogate index of cerebral metabolism, was signifi-
cantly lower under anaesthesia compared to the
awake state. The lack of demonstrable effects on
cerebral metabolism induced by the catecholamines
may be explained by the coupling of flow and
metabolism induced by anaesthesia. 
The mechanisms for the variable effects of cate-
cholamines on the cerebral circulation under physio-
logical and anaesthetized conditions are speculative,
but may be considered by analysing the individual
effects that catecholamines and anaesthetic agents
have on cerebrovascular function.
Under physiological conditions, exogenous cate-
cholamines do not cross the blood-brain barrier due
to anatomical and metabolic mechanisms. The
integrity of the endothelial cell lining of the cerebro-
vascular bed constitutes a morphological blood-brain
barrier mechanism to neurotransmitter catechola-
mines. The small percentage of amines that may pass
this membrane are deaminated within the endothelial
cells and pericytes of brain microvessels and, in the
case of large parenchymal and pial vessels, in the
smooth muscle layers
16. 
Selective transmission of dopamine may occur
across the natural defects in the blood-brain barrier
such as the posterior pituitary gland or pineal gland
which have specific dopaminergic receptors, or via
non-adrenergic central neural mechanisms
17,18.
Brief or sustained hypertensive stimuli that exceed
the upper cerebral autoregulatory threshold may
transiently open the blood-brain barrier through an
effect on endothelial cell linings. High circulating
concentrations of catecholamines can also open the
morphological barrier, but probably only indirectly by
inducing an acute rise in systemic blood pressure
16,19.
Once the blood-brain barrier is open, systemically
administered catecholamines may enter the brain
parenchyma, where they may induce pronounced
changes in cerebral blood flow and metabolism.
The effect of catecholamines such as adrenaline,
noradrenaline and dopamine on blood-brain barrier
permeability has been demonstrated in a number of
experimental models including labelled albumin
leakage
20, Evans blue
21 and horseradish peroxidase
tracers
22. The effects of catecholamines on cerebral
blood flow and metabolism were demonstrated using
various methods of cerebral blood flow measurement
including  14C ethanol
23, quantitative autoradio-
graphy
19 and hydrogen clearance techniques
24. A con-
sistent finding in these studies was that blood-brain
barrier permeability was altered by induced hyper-
tensive stimuli
19,25, particularly by dopamine and
adrenaline
22. This phenomenon has been implicated
in the pathogenesis of hypertensive encephalopathy
26.
Intravenous and inhalational anaesthetics have
direct cerebrovascular effects that are complex.
Propofol is regarded as an indirect cerebral vaso-
constrictor, whilst isoflurane is thought to be a pre-
dominant vasodilator. However, these mechanisms
remain unclear as there are variable effects on blood-
brain barrier permeability, flow-metabolism coupling
and myogenic autoregulation
27-30. 
Anaesthetic agents may affect blood-brain barrier
permeability. Direct effects of isoflurane on blood
brain transfer coefficients and capillary permeability-
surface area product have been demonstrated with 
1 and 2% isoflurane
31. Propofol has been shown to
independently increase the uptake of chemothera-
peutic agents such as melphalan and etoposide
phosphate across the blood-brain barrier following
osmotic disruption
3. The effects of propofol/nitrous
oxide anaesthesia on blood-brain barrier permeability
has been shown to be qualitatively and quanti-
tatively more pronounced than isoflurane/oxygen
anaesthesia
2. 
The clinical implications of this animal study are
significant. The use of catecholamine infusions in
patients receiving propofol or isoflurane anaesthesia
is common, particularly in patients with cerebral
pathology such as traumatic brain injury or subarach-
noid haemorrhage. If catecholamine-anaesthetic
interactions potentially alter blood-brain barrier
function under physiological conditions, it is likely
that this may be exacerbated under pathophysio-
logical conditions, thereby rendering the cerebral
circulation vulnerable to the direct effect of these
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requires further study. 
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